361 related articles for article (PubMed ID: 36597408)
1. Identification and comparison of m6A modifications in glioblastoma non-coding RNAs with MeRIP-seq and Nanopore dRNA-seq.
Krusnauskas R; Stakaitis R; Steponaitis G; Almstrup K; Vaitkiene P
Epigenetics; 2023 Dec; 18(1):2163365. PubMed ID: 36597408
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome-wide analysis of glioma stem cell specific m6A modifications in long-non-coding RNAs.
Steponaitis G; Stakaitis R; Valiulyte I; Krusnauskas R; Dragunaite R; Urbanavičiūtė R; Tamasauskas A; Skiriute D
Sci Rep; 2022 Mar; 12(1):5431. PubMed ID: 35361860
[TBL] [Abstract][Full Text] [Related]
3. N6-Methyladenosine Methylation Analysis of Long Noncoding RNAs and mRNAs in IPEC-J2 Cells Treated With
Yang J; Yang Q; Zhang J; Gao X; Luo R; Xie K; Wang W; Li J; Huang X; Yan Z; Wang P; Gun S
Front Immunol; 2021; 12():769204. PubMed ID: 34880865
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells.
Lai J; Zhou Z; Hu K; Yu H; Su X; Niu X; Li H; Mao S
Epigenetics; 2024 Dec; 19(1):2298058. PubMed ID: 38145548
[TBL] [Abstract][Full Text] [Related]
5. Deciphering the map of METTL14-mediated lncRNA m6A modification at the transcriptome-wide level in breast cancer.
Yi D; Xu F; Wang R; Jiang C; Qin J; Lee Y; Shi X; Sang J
J Clin Lab Anal; 2022 Dec; 36(12):e24754. PubMed ID: 36336884
[TBL] [Abstract][Full Text] [Related]
6. Benchmarking of computational methods for m6A profiling with Nanopore direct RNA sequencing.
Maestri S; Furlan M; Mulroney L; Coscujuela Tarrero L; Ugolini C; Dalla Pozza F; Leonardi T; Birney E; Nicassio F; Pelizzola M
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38279646
[TBL] [Abstract][Full Text] [Related]
7. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
[TBL] [Abstract][Full Text] [Related]
9. EpiNano: Detection of m
Liu H; Begik O; Novoa EM
Methods Mol Biol; 2021; 2298():31-52. PubMed ID: 34085237
[TBL] [Abstract][Full Text] [Related]
10. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome-wide N6-methyladenosine (m6A) methylation profiling of long non-coding RNAs in ovarian endometriosis.
Liu H; Liang J; Dai X; Peng Y; Xiong W; Zhang L; Li X; Li W; Liu K; Bi S; Wang X; Zhang W; Liu Y
Genomics; 2024 Mar; 116(2):110803. PubMed ID: 38290592
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance.
Yu R; Yu Q; Li Z; Li J; Yang J; Hu Y; Zheng N; Li X; Song Y; Li J; Chen X; Du W; Su J
Clin Epigenetics; 2023 Dec; 15(1):194. PubMed ID: 38098098
[TBL] [Abstract][Full Text] [Related]
13. The N
Li B; Zhao R; Qiu W; Pan Z; Zhao S; Qi Y; Qiu J; Zhang S; Guo Q; Fan Y; Xu H; Li M; Li G; Xue H
Theranostics; 2022; 12(14):6363-6379. PubMed ID: 36168628
[No Abstract] [Full Text] [Related]
14. MoAIMS: efficient software for detection of enriched regions of MeRIP-Seq.
Zhang Y; Hamada M
BMC Bioinformatics; 2020 Mar; 21(1):103. PubMed ID: 32171255
[TBL] [Abstract][Full Text] [Related]
15. Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study.
Yang L; Liu J; Jin Y; Xing J; Zhang J; Chen X; Yu A
Sci Rep; 2024 May; 14(1):10427. PubMed ID: 38714753
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine methylation mediates non-coding RNAs modification in microplastic-induced cardiac injury.
Zhang M; Shi J; Zhou J; Song L; Ding J; Deng HP; Weng L; Zhu Y; Xu Z
Ecotoxicol Environ Saf; 2023 Jun; 262():115174. PubMed ID: 37354568
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine modified lncRNAs signature for stratification of biochemical recurrence in prostate cancer.
Liang Y; Yin W; Cai Z; Luo H; Liu Q; Zhong C; Chen J; Lin Z; Huang Y; Liang Z; Deng J; Zhong W; Cai C; Lu J
Hum Genet; 2023 Sep; ():. PubMed ID: 37758909
[TBL] [Abstract][Full Text] [Related]
18. The alteration of N6-methyladenosine (m6A) modification at the transcriptome-wide level in response of heat stress in bovine mammary epithelial cells.
Qi Y; Zhang Y; Zhang J; Wang J; Li Q
BMC Genomics; 2022 Dec; 23(1):829. PubMed ID: 36517742
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of N6-methyladenosine modification patterns in t(8;21) acute myeloid leukemia].
Wen Y; Fang S; Yang J; Wang H; Jiao Y; Wang N; Wei Y; Wang L; Dou L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):690-697. PubMed ID: 35673912
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of lncRNAs N
Zuo L; Su H; Zhang Q; Wu WY; Zeng Y; Li XM; Xiong J; Chen LF; Zhou Y
Aging (Albany NY); 2021 Jan; 13(3):4182-4198. PubMed ID: 33493136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
